Section 501 – Operating requirements — General.
Effective 3/23/2022 26-61a-501. Operating requirements — General. (1) (a) A medical cannabis pharmacy shall operate: (i) at the physical address provided to the department under Section 26-61a-301; and (ii) in accordance with the operating plan provided to the department under Section 26-61a-301 and, if applicable, Section 26-61a-304. (b) A medical cannabis pharmacy shall notify the […]
Section 502 – Dispensing — Amount a medical cannabis pharmacy may dispense — Reporting — Form of cannabis or cannabis product.
Effective 3/23/2022 26-61a-502. Dispensing — Amount a medical cannabis pharmacy may dispense — Reporting — Form of cannabis or cannabis product. (1) (a) A medical cannabis pharmacy may not sell a product other than, subject to this chapter: (i) cannabis in a medicinal dosage form that the medical cannabis pharmacy acquired from another medical cannabis […]
Section 301 – Medical cannabis pharmacy — License — Eligibility.
Effective 3/23/2022 26-61a-301. Medical cannabis pharmacy — License — Eligibility. (1) A person may not operate as a medical cannabis pharmacy without a license that the department issues under this part. (2) (a) (i) Subject to Subsections (4) and (5) and to Section 26-61a-305, the department shall issue a license to operate a medical cannabis […]
Section 302 – Medical cannabis pharmacy owners and directors — Criminal background checks.
Effective 9/23/2019 26-61a-302. Medical cannabis pharmacy owners and directors — Criminal background checks. (1) Each applicant to whom the department issues a notice of intent to award a license to operate as a medical cannabis pharmacy shall submit, before the department may award the license, from each individual who has a financial or voting interest […]
Section 303 – Renewal.
Effective 3/23/2022 26-61a-303. Renewal. (1) The department shall renew a license under this part every year if, at the time of renewal: (a) the licensee meets the requirements of Section 26-61a-301; (b) the licensee pays the department a license renewal fee in an amount that, subject to Subsection 26-61a-109(5), the department sets in accordance with […]
Section 111 – Nondiscrimination for medical care or government employment — Notice to prospective and current public employees — No effect on private employers.
Effective 3/23/2022 26-61a-111. Nondiscrimination for medical care or government employment — Notice to prospective and current public employees — No effect on private employers. (1) For purposes of medical care, including an organ or tissue transplant, a patient’s use, in accordance with this chapter, of cannabis in a medicinal dosage form or a cannabis product […]
Section 112 – No insurance requirement.
Effective 12/3/2018 26-61a-112. No insurance requirement. Nothing in this chapter requires an insurer, a third-party administrator, or an employer to pay or reimburse for cannabis, a cannabis product, or a medical cannabis device. Enacted by Chapter 1, 2018 Special Session 3
Section 113 – No effect on use of hemp extract — Cannabidiol — Approved drugs.
Effective 5/12/2020 26-61a-113. No effect on use of hemp extract — Cannabidiol — Approved drugs. (1) Nothing in this chapter prohibits an individual from purchasing, selling, possessing, or using a cannabinoid product in accordance with Section 4-41-402. (2) Nothing in this chapter restricts or otherwise affects the prescription, distribution, or dispensing of a product that […]
Section 114 – Severability clause.
Effective 12/3/2018 26-61a-114. Severability clause. (1) If any provision of this title or Laws of Utah 2018, Third Special Session, Chapter 1 or the application of any provision of this title or Laws of Utah 2018, Third Special Session, Chapter 1 to any person or circumstance is held invalid by a final decision of a […]
Section 115 – Analogous to prescribed controlled substances.
Effective 9/23/2019 26-61a-115. Analogous to prescribed controlled substances. When an employee, officer, or agent of the state or a political subdivision makes a finding, determination, or otherwise considers an individual’s possession or use of cannabis, a cannabis product, or a medical cannabis device, the employee, officer, or agent may not consider the individual’s possession or […]